SPHINGOSINE- AND CERAMIDE-ANALOG TOXINS—AN UPDATE

REFERENCES

• Carter G. T., Rinehart K. L., Jr. Aplidiasphingosine, an Antimicrobial and Antitumor Terpenoid from an Aplidium sp. (Marine Tunicate). J. Am. Chem. Soc. 1978; 100: 7441–7442
   Google Scholar
• Wang E., Norred W. P., Bacon C. W., Riley R. T., Merrill A. H., Jr. Inhibition of Sphingolipid Biosynthesis by Fumonisins. J. Biol. Chem. 1991; 266: 14486–14490
   PubMed Web of Science ®Google Scholar
• Shier W. T. Sphingosine Analogs: An Emerging New Class of Toxins that Includes the Fumonisins. J. Toxicol.-Toxin Rev. 1992; 11: 241–257
   Google Scholar
• Hannun Y. A., Bell R. M. Lysophingolipids Inhibit Protein Kinase C: Implications for the Sphingolipidoses. Science 1987; 235: 670–674
   PubMed Web of Science ®Google Scholar
• Hannun Y. A. The Sphingomyelin Cycle and the Second Messenger Function of Ceramide. J. Biol. Chem. 1994; 269: 3125–3128
   PubMed Web of Science ®Google Scholar
• Hannun Y. A., Linardic C. M. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochimica et Biophysica Acta 1993; 1154: 223–236
   PubMed Web of Science ®Google Scholar
• Perry D. K., Hannun Y. A. The role of ceramide in cell signaling. Biochemica et Biophysica Acta 1998; 1436: 233–243
   PubMed Web of Science ®Google Scholar
• Hannun Y. A., Luberto C. C. Ceramide in the Eukaryotic Stress Response. Cell Biol. 2000; 10: 73–80
   Google Scholar
• Kobayashi J., Ishibashi M. Sphingosine-Related Marine Alkaloids: Cyclic Amino Alcohols. Heterocycles 1996; 42: 943–970
   Web of Science ®Google Scholar
• Ueno Y., Sugiura Y., Iijima K., Kawamura S. Natural Toxin Series: (2) A Sphingosine-like Mycotoxin, Fumonisin. Journal of Toxicological Sciences 1996; 21: 27–39
   PubMedGoogle Scholar
• Harvey A. L. Cytolytic Toxins, in. Handbook of Toxinology, W. T. Shier, D. Mebs. Marcel Dekker, Inc., New York 1990; 1–66
   Google Scholar
• Rosenberg P. Phospholipases, in. Handbook of Toxinology, W. T. Shier, D. Mebs. Marcel Dekker, Inc., New York 1990; 67–277
   Google Scholar
• Forrester L. J., Barrett L. T., Campbell B. J. Red Blood Cell Lysis Induced by the Venom of the Brown Recluse Spider: The Role of Sphingomyolinase D. Arch. Biochem. Biophys. 1978; 187: 335
   PubMedGoogle Scholar
• Shier W. T. Cytolytic Mechanisms: Self-destruction of Mammalian Cells by Activation of Endogenous Hydrolytic Enzymes. Toxicol.-Toxin Reviews 1982; 1: 1–32
   Google Scholar
• Hannun Y. A., Loomis C. R., Merrill A. H., Jr., Bell R. M. Sphingosine Inhibition of Protein Kinase C Activity and of Phorbol Dibutyrate Binding in Vitro and in Human Platelets. J. Biol. Chem. 1986; 261: 12604–12609
   PubMed Web of Science ®Google Scholar
• Hannun Y. A., Bell R. M. The Sphingomyelin Cycle: A Prototypic Sphingolipid Signaling Pathway. Advances Lipid Res. 1993; 25: 27–41
   PubMedGoogle Scholar
• Obeid L. M., Linardic C. M., Karolak L. A., Hannun Y. A. Programmed Cell Death Induced by Ceramide. Science 1993; 259: 1769–1771
   PubMed Web of Science ®Google Scholar
• Hannun Y. A., Obeid L. M. Ceramide: an intracellular signal for apoptosis. TIBS 1995; 20: 73–77
   PubMed Web of Science ®Google Scholar
• Luberto C., Hannun Y. A. Sphingolipid Metabolism in the Regulation of Bioactive Molecules. Lipids 1999; 34: S5–S10
   PubMedGoogle Scholar
• Merrill A. H., Jr., Hannun Y. A., Bell R. M. Introduction: Sphingolipids and Their Metabolites in Cell Regulation. Advances Lipid Res. 1993; 25: 1–24
   PubMedGoogle Scholar
• Hannun Y. A., Obeid L. M., Wolff R. A. The Novel Second Messenger Ceramide: Identification, Mechanism of Action, and Cellular Activity. Advances Lipid Res. 1993; 25: 43–64
   PubMedGoogle Scholar
• Spiegel S., Milstien S. Sphingolipid metabolites: Members of a new class of lipid second messengers. J. Membr. Biol. 1995; 146: 225–237
   PubMed Web of Science ®Google Scholar
• Hakomori S-I. Sphingolipid-Dependent Protein Kinases. Advances in Pharmacology 1997; 36: 155–171
   Google Scholar
• Hakomori S-I., Yamamura S., Handa K. Signal Transduction Through Glyco(sphingo)lipids. Ann. New York Acad. Sci. 1998; 845: 1–10
   PubMed Web of Science ®Google Scholar
• Hakomori S-I. Tumor Malignancy Defined by Aberrant Glycosylation and Sphingo(glyco)lipid Metabolism. Perspectives Cancer Res. 1996; 56: 5309–5318
   PubMed Web of Science ®Google Scholar
• Hakomori S-I. Cancer-Associated Glycosphingolipid Antigens: Their Structure, Organization, and Function. Acta Anat. 1998; 161: 79–90
   PubMedGoogle Scholar
• Merrill A. H., Jones D. D. An update of the enzymology and regulation of sphingomyelin metabolism. Biochimica et Biophysica Acta 1990; 1044: 1–12
   PubMed Web of Science ®Google Scholar
• Merrill A. H., Schmelz E-M., Dillehay D. L., Spiegel S., Shayman J. A., Schroeder J. J., Riley R. T., Voss K. A., Wang E. Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology and Pathophysiology. Toxicol. Appl. Pharmacol. 1997; 142: 208–225
   PubMed Web of Science ®Google Scholar
• Megidish T., Takio K., Titani K., Iwabuchi K., Hamaguchi A., Igarashi Y., Hakomori S-I. Endogenous Substrates of Sphingosine-Dependent Kinases (SDKs) Are Chaperone Proteins: Heat Shock Proteins, Glucose-Regulated Proteins, Protein Disulfide Isomerase, and Calreticulin. Biochem. 1999; 38: 3369–3378
   PubMed Web of Science ®Google Scholar
• Bornfeldt K. E., Graves L. M., Raines E. W., Igarashi Y., Wayman G., Yamamura S., Yatomi Y., Sidhu J. S., Krebs E. G., Hakomori S., Ross R. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction. J. Cell Biol. 1995; 130: 193–206
   PubMed Web of Science ®Google Scholar
• Merrill A. H., Sereni A. M., Stevens V. L., Hannun Y. A., Bell R. M., Kinkade J. M., Jr. Inhibition of Phorbol Ester-dependent Differentiation of Human Promyelocytic Leukemic (HL-60) Cells by Sphinganine and Other Long-chain Bases. J. Biol. Chem. 1986; 261: 12610–12615
   PubMed Web of Science ®Google Scholar
• Nelson D. H., Murray D. K. Sphingolipids Inhibit Insulin and Phorbol Ester Stimulated Uptake of 2-Deoxyglucose. Biochem. Biophys. Res. Comm. 1986; 138: 463–467
   PubMedGoogle Scholar
• Hall F. L., Fernyhough P., Ishii D. N., Vuliet P. R. Suppression of Nerve Growth Factor-directed Neurite Outgrowth in PC12 Cells by Sphingosine, an Inhibitor of Protein Kinase C. J. Biol. Chem. 1988; 263: 4460–4466
   PubMedGoogle Scholar
• Igarashi Y., Sadahira Y., Yamamura S., Hakomori S. Inhibition of Mouse B16 Melanoma Cell Motility by Sphingosine-1-Phosphate Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, K. V. Honn. Plenum Press, New York 1997; 693–698
   Google Scholar
• Olivera A., Spiegel S. Sphingosine-1-phosphate as a Second Messenger in Cell Proliferation Induced by PDGF and FCS Mitogens. Nature 1993; 365: 557–560
   PubMed Web of Science ®Google Scholar
• Ghosh T. K., Bian J., Gill D. L. Intracellular Calcium Release Mediated by Sphingosine Derivatives Generated in Cells. Science 1990; 248: 1653–1656
   PubMed Web of Science ®Google Scholar
• Ghosh T. K., Bian J., Gill D. L. Sphingosine 1-phosphate Generated in the Endoplasmic Reticulum Membrane Activates Release of Stored Calcium. J. Biol. Chem. 1994; 269: 22628–22635
   PubMed Web of Science ®Google Scholar
• Zhang H., Desai N. N., Murphey J. M., Spiegel S. Increases in Phosphatidic Acid Levels Accompany Sphingosine-stimulated Proliferation of Quiescent Swiss 3T3 Cells. J. Biol. Chem. 1990; 265: 21309–21316
   PubMed Web of Science ®Google Scholar
• Lavie Y., Piterman O., Lisovitch M. Inhibition of Phosphatidic Acid Phosphohydrolase Activity by Sphingosine. Dual Action of Sphingosine in Diacylglycerol Signal Termination. Fed. Eur. Biol. Soc. 1990; 277: 7–10
   PubMedGoogle Scholar
• Wu J., Spiegel S., Stugill T. W. Sphingosine-1-phosphate Rapidly Activates the MAP Kinase Pathway by a G-protein Dependent Mechanism. J. Biol. Chem. 1995; 270: 11484–11488
   PubMed Web of Science ®Google Scholar
• Igarashi Y., Hakomori S. Enzymatic Synthesis of N,N-Dimethyl-sphingosine: Demonstration of the Sphingosine:N-methyltransferase in Mouse Brain. Biochem. Biophys. Res. Commun. 1989; 164: 1411–1416
   PubMed Web of Science ®Google Scholar
• Igarashi Y., Kitamura K., Toyokuni T., Dean B., Fenderson B. A., Ogawa T., Hakomori S. A Specific Enhancing Effect of N,N-Dimethylsphingosine on Epidermal Growth Factor Receptor Autophosphorylation: Demonstration of its Endogenous Occurrence (and the Virtual Absence of Unsubstituted Sphingosine) in Human Epidermoid Carcinoma A431 Cells. J. Biol. Chem. 1990; 265: 5385–5389
   PubMed Web of Science ®Google Scholar
• Okazaki T., Bell R. M., Hannun Y. A. Sphingomyelin Turnover Induced by Vitamin D3 in HL-60 Cells. Role in Cell Differentiation. J. Biol. Chem. 1989; 264: 19076–19080
   PubMed Web of Science ®Google Scholar
• Olivera A., Spiegel S. Sphingomyelinase and Cell-permeable Ceramide Analogs Stimulate Cellular Proliferation in Quiescent Swiss 3T3 Fibroblasts. J. Biol. Chem. 1992; 267: 26121–26127
   PubMedGoogle Scholar
• Chang Y., Abe A., Shayman J. A. Ceramide formation during heat shock: A potential mediator of αB-crystallin transcription. Proc. Natl. Acad. Sci. USA 1995; 92: 12275–12279
   PubMedGoogle Scholar
• Raines M. A., Kolesnick R. N., Golde D. W. Sphingomyelinase and Ceramide Activate Mitogen-Activated Protein Kinase in Myeloid HL-60 Cells. J. Biol. Chem. 1993; 268: 14572–14575
   PubMedGoogle Scholar
• Dobrowsky R. T., Hannun Y. A. Ceramide Stimulates a Cytosolic Protein Phosphatase. J. Biol. Chem. 1992; 267: 5048–5051
   PubMed Web of Science ®Google Scholar
• Schutze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann D., Kronke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “acidic” sphingomyelin breakdown. Cell 1992; 71: 765–776
   PubMed Web of Science ®Google Scholar
• Inokuchi L., Mason I., Radin N. S. Antitumor activity via inhibition of glycosphingolipid biosynthesis. Cancer Lett. 1987; 38: 23–30
   PubMed Web of Science ®Google Scholar
• Shayman J. A., Deshmukh G. D., Mahdiyoun S., Thomas T. P., Barcelon F. S., Radin N. S. Modulation of Renal Epithelial Cell Growth by Glucosylceramide: Association with Protein Kinase C, Sphingosine, and Diacylglyceride. J. Biol. Chem. 1991; 266: 22968–22974
   PubMedGoogle Scholar
• Yang H.-J., Hakomori S.-I. A Sphingolipid Having a Novel Type of Ceramide and Lacto-N-fucopentanose III. J. Biol. Chem., 246: 1192–1200
   PubMedGoogle Scholar
• Nudelman E. D., Kannagi R., Hakomori S.-I., Parsons M., Lipinski M., Wiels J., Fellous M., Turz T. A Glycolipid Antigen Associated with Burkitt Lymphoma Defined by a Monoclonal Antibody. Science 1983; 220: 509–511
   PubMed Web of Science ®Google Scholar
• Hakomori S. I., Wang S.-M., Young W. W.J. Isoantigenic Expression of Forssman Glycolipid in Human Gastric and Colonic Mucosa: Its Possible Identity with “A-like Antigen” in Human Cancer. Proc. Natl. Acad. Sci. U.S.A. 1977; 74: 3023–3027
   PubMed Web of Science ®Google Scholar
• Danishefsky S. J., Allen J. R. From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines. Angew. Chem. Int. Ed. 2000; 39: 836–863
   PubMed Web of Science ®Google Scholar
• Shier W. T. Preparation of a Chemical Vaccine Against Tumor Progression. Proc. Nat. Acad. Sci. USA 1971; 68: 2078–2082
   PubMed Web of Science ®Google Scholar
• Shier W. T. Modification of Tumor Growth with a Defined Glycoprotein Antigen. Nature 1973; 244: 99–101
   PubMedGoogle Scholar
• Iwabuchi K., Handa K., Hakomori S-I. Separation of “Glycosphingolipid Signaling Domain” from Caveolin-containing Membrane Fraction in Mouse Melanoma B16 Cells and Its Role in Cell Adhesion Coupled with Signaling. J. Biol. Chem. 1998; 273: 33766–33773
   PubMedGoogle Scholar
• Sandvig K., Garred O., van Helvoort A., van Meer G., van Deurs B. Importance of Glycolipid Synthesis for Butyric Acid-induced Sensitization to Shiga Toxin and Intracellular Sorting of Toxin in A431 Cells. Mol. Biol. Cell 1996; 7: 1391–1404
   PubMedGoogle Scholar
• Yoshida T., Chen C., Zhang M., Wu H. C. Disruption of the Golgi Apparatus by Brefeldin A Inhibits the Cytotoxicity of Ricin, Modeccin and Pseudomonas Toxin. Exp. Cell Res. 1991; 192: 389–395
   PubMedGoogle Scholar
• Sandvig K., Dubinina E., Garred O., Prydz K., Kozlov J. V., Hansen S. H., van Deurs B. Protein Toxins: Mode of Action and Cell Entry. Biochem. Soc. Tran. 1992; 20: 724–727
   PubMedGoogle Scholar
• Merrill A. Characterization of Serine Palmitoyltransferase Activity in Chinese Hamster Ovary Cells. Biochim. Biophys. Acta 1983; 754: 284
   PubMedGoogle Scholar
• Merrill A. H., Jr., Wang E., Gilchrist D. G., Riley R. T. Fumonisins and Other Inhibitors of De Novo Sphingolipid Biosynthesis. In. Advances in Lipid Research: Sphingolipids and Their Metabolites, R. M. Bell, Y. A. Hannun, A. H. Merrill. Academic Press, San Diego 1993; 26: 215–234
   Google Scholar
• Medlock K. A., Merrill A. H., Jr. Inhibition of Serine Palmitoyltransferase In Vitro and Long-chain Base Biosynthesis in Intact Chinese Hamster Ovary Cells by beta-Chloroalanine. Biochemistry 1988; 27: 7079–7084
   PubMedGoogle Scholar
• Zweerink M. M., Edison A. M., Wells G. B., Pinto W., Lester R. L. Characterization of a Novel, Potent, and Specific Inhibitor of Serine Palmitoyltransferase. J. Biol. Chem. 1992; 267: 25032–25038
   PubMedGoogle Scholar
• Miyake Y., Kozutsumi Y., Nakamura S., Fujita T., Kawasaki T. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem. Biosphys. Res. Commun. 1995; 211: 396–403
   PubMed Web of Science ®Google Scholar
• Mandala S. M., Frommer B. R., Thornton R. A., Kurtz M. B., Young N. M., Cabello M. A., Genilloud O., Liesch J. M., Smith J. L., Horn W. S. Inhibition of serine palmitoyltransferase activity by lipoxamycin. J. Antibiot. (Japan) 1995; 47: 349–356
   Google Scholar
• Wang E., Norred W. P., Bacon C. W., Riley R. T., Merrill A. H., Jr. Inhibition of Sphingolipid Biosynthesis by Fumonisins. J. Biol. Chem. 1991; 266: 14486–14490
   PubMed Web of Science ®Google Scholar
• Wang E., Ross P. F., Wilson T. M., Riley R. T., Merrill A. H., Jr. Alteration of serum sphingolipids upon dietary exposure of ponies to fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr. 1992; 122: 1706–1716
   PubMed Web of Science ®Google Scholar
• Yoo H.-S., Norred W. P., Wang E., Merrill A. H., Jr., Riley R. T. Fumonisin Inhibition of De Novo Sphingolipid Biosynthesis and Cytotoxicity are Correlated in LLC-PK1 Cells. Toxicol. Appl. Pharmacol. 1992; 114: 9–15
   PubMed Web of Science ®Google Scholar
• Riley R. T., An N. H., Showker J. L., Yoo H.-S., Norred W. P., Chamberlain W. J., Wang E., Merrill A. H., Jr., Motelin G., Beasley V. R., Haschek W. M. Alteration of tissue and serum sphinganine to sphingosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol. Appl. Pharmacol. 1993; 118: 105–112
   PubMed Web of Science ®Google Scholar
• Riley R. T., Hinton D. M., Chamberlain W. J., Bacon C. W., Wang E., Merrill A. H., Jr., Voss K. A. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: A new mechanism of nephrotoxicity. J. Nutr. 1994; 124: 594–603
   PubMed Web of Science ®Google Scholar
• Abbas H. K., Tanaka T., Duke S. O., Porter J. K., Wray E. M., Hodges L., Sessions A. E., Wang E., Merrill A. H., Jr., Riley R. T. Fumonisin and AAL-toxin-induced disruption of sphingolipid metabolism with accumulation of free sphingoid bases. Plant Physiol. 1994; 106: 1085–1093
   PubMed Web of Science ®Google Scholar
• Yoo H-S., Norred W. P., Showker J., Riley R. T. Elevated Sphingoid Bases and Complex Sphingolipid Depletion as Contributing Factors in Fumonisin-Induced Cytotoxicity. Toxicology and Applied Pharmacology 1996; 138: 211–218
   PubMed Web of Science ®Google Scholar
• Humpf H.-U., Schmelz E.-M., Meredith F. I., Merrill A. H. N-Palmitoyl-HFB1: A New Metabolite of Hydrolyzed Fumonisin (HFB1) in Rat Liver Microsomes. Revue Méd. Vét. 1998; 149: 576
   Google Scholar
• Humpf H. U., Schmelz E. M., Meredith F. I., Vesper H., Vales T. R., Wang E., Menaldino D. S., Liotta D. C., Merrill A. H., Jr. Acylation of Naturally Occurring and Synthetic 1-Deoxysphinganines by Ceramide Synthase. Formation of N-palmitoyl-aminopentol Produces a Toxic Metabolilte of Hydrolyzed Fumonisin, AP1, and a New Category of Ceramide Synthase Inhibitor. J. Biol. Chem. 1998; 273: 19060–19064
   PubMed Web of Science ®Google Scholar
• Mandala S. M., Thornton R. A., Frommer B. R., Curotto J. E., Rozdilsky W., Kurtz M. B., Giacobbe R. A., Bills G. F., Cabello M. A., Martin I., Pelaez F., Harris G. H. The discovery of auastralifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporomiella australis producing organism, fermentation, isolation, and biological activity. J. Antibiot. (Japan) 1995; 48: 349–356
   PubMed Web of Science ®Google Scholar
• Barbour S., Edidin M., Felding-Habermann B., Taylor-Norton J., Radin N. S., Fenderson B. A. Glycolipid Depletion Using A Ceramide Analog (PDMP) Alters Growth, Adhesion, and Membrane Lipid Organization in Human A431 Cells. J. Cell. Phys. 1992; 150: 610–619
   PubMedGoogle Scholar
• Kedderis L. B., Bozigian H. P., Kleeman J. M., Hall R. L., Palmer T. E., Harrison S. D., Jr., Susick R. L., Jr. Toxicity of the Protein C Inhibitor Safingol Administered Alone and in Combination with Chemotherapeutic Agents. Fundamental and Applied Toxicology 1995; 25: 210–217
   Google Scholar
• Bielawska A., Greenberg M. S., Perry D., Jayadev S., Shayman J. A., McKay C., Hannun Y. A. (IS, 2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J. Biol. Chem. 1996; 271: 12646–12654
   PubMed Web of Science ®Google Scholar
• Gulavita N. K., Scheuer P. J. Two Epimeric Aliphatic Amino Alcohols from a Sponge, Xestospongia sp. J. Org. Chem. 1989; 54: 366–369
   Google Scholar
• Jimenez C., Crews P. Novel Marine Sponge Amino Acids, 10. Xestoaminols from Xestospongia sp. J. of Nat. Products 1990; 53: 978–982
   PubMedGoogle Scholar
• Mori K., Matsuda H. Synthesis and Absolute Configuration of the Two Epimeric Aliphatic Amino Alcohols [(5E, 7E)-2-Amino-5,7-tetradecadien-3-ols] Isolated from a Sponge Xestospongia sp. Liebigs. Ann. Chem. 1992; 1992: 131–137
   Google Scholar
• Merriman G., Tegeler J. J., Hamer R. R.L., Rauckman B. S., Freed B. S., Kurtz E. S., Bailey S. C., Ortega-Nanos M., Przekop P. A., Hellyer L. The Enantioselective Synthesis and Antiinflammatory Activity of Novel Aryl-Sphingolipid PKC Inhibitors. Bioorg. and Med. Chem. Lett. 1995; 5: 2483–2488
   Google Scholar
• Jares-Erijman E., Bapat C. P., Lithgow-Bertelloni A., Rinehart K. L., Sakai R. Crucigasterins, New Polyunsaturated Amino Alcohols from the Mediterranean Tunicate Pseudodistoma crucigaster. J. Org. Chem. 1993; 58: 5732–5737
   Google Scholar
• Whaley H. A. The Structure of Lipoxamycin, a Novel Antifungal Antibiotic. J. Amer. Chem. Soc. 1971; 93: 3767–3769
   PubMedGoogle Scholar
• Ishibashi M., Ohizumi Y., Sasaki T., Nakamura H., Hirata Y., Kobayashi J. Pseudodistomins A and B, Novel Antineoplastic Piperidine Alkaloids with Calmodulin Antagonistic Activity from the Okinawan Tunicate. Pseudodistoma kanoko, J. Org. Chem. 1987; 52: 450–453
   Google Scholar
• Kiguchi T., Yuumoto Y., Ninomiya I., Naito T., Deki K., Ishibashi M., Kobayashi J. Pseudodistomin B: Revised Structure and First Total Synthesis. Tetrahedron Lett. 1992; 33: 7389–7390
   Google Scholar
• Kobayashi J., Naitoh K., Doi Y., Deki K., Ishibashi M. Pseudodistomin C, a New Piperidine Alkaloid with Unusual Absolute Configuration from the Okinawan Tunicate. Pseudodistoma kanoko, J. Org. Chem. 1995; 60: 6941–6945
   Google Scholar
• Doi Y., Ishibashi M., Kobayashi J. Total Synthesis of Pseudodistomin C, a Sphingosine-Related Piperidine Alkaloid from Tunicate. Pseudodistoma kanoko, Tetrahedron 1996; 52: 4573–4580
   Google Scholar
• Kobayashi J., Cheng J., Ishibashi M., Wachli M., Yamamura S., Ohizumi Y. Penaresidin A and B, Two Novel Azetidine Alkaloids with Potent Actomyosin ATPase-Activating Activity from the Okinawan Marine Sponge Penares sp. J. Chem. Soc. Perkin Trans. 1991; 1135–1137
   Google Scholar
• Bezuidenhout S. C., Gelderblom W. C. A., Gorst-Allman C. P., Horak R. M., Marasas W. F. O., Spiteller G., Vleggaar R. Structure Elucidation of the Fumonisins, Mycotoxins from. Fusarium moniliforme, J. Chem. Soc. Chem. Commun. 1988; 1988: 743–745
   Google Scholar
• Knapp S., Dong Y. Stereoselective Synthesis of Penaresidin A and Related Azetidine Alkaloids. Tetrahedron Lett. 1997; 38: 3813–3816
   Web of Science ®Google Scholar
• Alvi K. A., Jaspars M., Crews P. Penazetidine A, an Alkaloid Inhibitor of Protein Kinase C. Bioorg. and Med. Chem. Lett. 1994; 4: 2447–2450
   Google Scholar
• Raub M., Cardellina J. H. II. Clavepictines A and B: Cytotoxic Quinolizidines from the Tunicate. Clavelina picta, J. Am. Chem. Soc. 1991; 113: 3178–3180
   Web of Science ®Google Scholar
• Kong F., Faulkner D. J., Pictamine A. Quinolizidine Alkaloid from the Tunicate. Clavelina picta, Tetrahedron Lett. 1991; 32: 3667–3668
   Google Scholar
• Steffan B., Lepadin A. A Decahydroquinoline Alkaloid from the Tunicate. Clavelina lepadiformis, Tetrahedron 1991; 47: 8729–8732
   Web of Science ®Google Scholar
• Kluepfel D., Bagli J., Baker H., Charest M-P., Kudelski A., Sehgal S. N., Vezina C. Myriocin, A New Antifungal Antibiotic from. Myriococcum albomyces, J. Antibiotics 1972; 25: 109–115
   PubMed Web of Science ®Google Scholar
• Bagli J. F., Kluepfel D., Jacques M., St. Elucidation of Structure and Stereochemistry of Myriocin. A Novel Antifungal Antibiotic. J. Org. Chem. 1973; 38: 1253–1260
   PubMedGoogle Scholar
• Aragozzini F., Manachini P. L., Craveri R., Rindone B., Scolastico C. Isolation and Structure Determination of a New Antifungal α-hydroxymethyl-α-amino Acid. Tetrahedron 1972; 28: 5493–5498
   Web of Science ®Google Scholar
• Destro R., Colombo A. Crystal Structure and Relative Configuration of the N-Acetyl-γ-lactone of the Antifungal Antibiotic Thermozymocidin. J. C. S. Perkin II 1978; 896–899
   Google Scholar
• Fujita T., Inoue K., Yamamoto S., Ikumoto T., Sasaki S., Toyama R., Chiba K., Hoshino Y., Okumoto T. Fungal Metabolites. Part 11. A Potent Immunosuppressive Activity Found in Isaria sinclairii Metabolite. J. Antibiotics 1994; 208–215
   PubMedGoogle Scholar
• Sasaki S., Hashimoto R., Kiuchi M., Inoue K., Ikumoto T., Hirose R., Chiba K., Hoshino Y., Okumoto T., Fujita T. Fungal Metabolites. Part 14. Novel Potent Immunosuppressants, Mycesterincins, Produced by. Mycelia sterilia, J. Antibiotics 1994; 420–433
   Google Scholar
• Banfi L., Beretta M. G., Colombo L., Gennari C., Scolastico C. Total Synthesis of (+)-Thermozymocidin (Myriocin) from D-Fructose. J. Chem. Soc., Chem. Commun. 1982; 488–490
   Google Scholar
• Banfi L., Beretta M. G., Colombo L., Gennari C., Scolastico C. 2-Benzoylamino-2-deoxy-2-hydroxymethyl-D-hexono-1,4-lactones: Synthesis from D-Fructose and Utilization in the Total Synthesis of Thermozymocidin (Myriocin). J. Chem. Soc. Perkin Trans. I. 1983; 1613–1619
   Google Scholar
• Trost B. M., Lee C. B. A New Strategy for the Synthesis of Sphingosine Analogues. Sphingofungin F. J. Am. Chem. Soc. 1998; 120: 6818–6819
   Google Scholar
• Fujita T., Inoue K., Yamamoto S., Ikumoto T., Sasaki S., Toyama R., Yoneta M., Chiba K., Hoshino Y., Okumoto T. Fungal Metabolites, Part 12. Potent Immunosuppressant, 14-deoxomyriocin, (2S, 3R, 4R)-(E)-2-amino-3,4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure-activity relationships of myriocin derivatives. J. Antibiotics 1994; 216–224
   PubMedGoogle Scholar
• Mukhopadhyay T., Roy K., Coutinho L., Rupp R. H., Ganguli B. N. Fumifungin, A New Antifungal Antibiotic from Aspergillus fumigatus fresenius 1863. J. Antibiotics 1987; 1050–1052
   PubMedGoogle Scholar
• VanMiddlesworth F., Ciacobbe R. A., Lopez M., Garrity G., Bland J. A., Bartizal K., Fromtling R. A., Polishook J., Zweerink M., Edison A. M., Rozdilsky W., Wilson K. E., Monaghan R. L. Spingofungins A, B, C, and D; A New Family of Antifungal Agents. J. Antibiotics 1992; 45: 861–867
   PubMed Web of Science ®Google Scholar
• VanMiddlesworth F., Dufresne C., Wincott F. E., Mosley R. T., Wilson K. E. Determination of the Relative and Absolute Stereochemistry of Sphingofungins A, B, C, and D. Tetrahedron Lett. 1992; 33: 297–300
   Web of Science ®Google Scholar
• Horn W. S., Smith J. L., Bills G. F., Raghoobar S. L., Helms G. L., Kurtz M. B., Marrinan J. A., Frommer B. R., Thornton R. A., Mandala S. M. Sphingofungins E and F: Novel Serinepalmitoyl Transferase Inhibitors from. Paecilomyces variotii, J. Antibiotics 1992; 1693–1696
   Google Scholar
• Bottini A. T., Gilchrist D. G., Phytotoxins I. A 1-Aminodimethyl-heptadecapentol from Alternaria alternata f. sp. Lycopersici, Tetrahedron Lett. 1981; 22: 2719–2722
   Web of Science ®Google Scholar
• Bottini A. T., Bowen J. R., Gilchrist D. G., Phytotoxins, II. Characterization of a Phytotoxic Fraction from Alternaria alternata f. sp. Lycopersici, Tetrahedron Lett. 1981; 22: 2723–2726
   Google Scholar
• Gelderblom W. C. A., Jaskiewicz K., Marasas W. F.O., Theil P. G., Horak R. M., Vleggaar R., Kreik N. P. J. Fumonisins—Novel Mycotoxins with Cancer-promoting Activity Produced by. Fusarium moniliforme, Appl. Environ. Microbiol. 1988; 54: 1806–1811
   PubMed Web of Science ®Google Scholar
• Abbas H. K., Duke S. O., Merrill A. H., Jr., Wang E., Shier W. T. Phytotoxicity of australifungin, AAL-toxins and fumonisin B1 to. Lemna pausicostata. Phytochemistry 1998; 47: 1509–1514
   Google Scholar
• Abbas H. K., Tanaka T., Shier W. T. Biological activities of synthetic analogs of Alternaria alternata toxin (AAL-toxin) and fumonisin in plant and mammalian cell cultures. Phytochemistry 1998; 40: 1681–1689
   Google Scholar
• Tatematsu M., Shirai T., Tsuda H., Miyata Y., Shinohara Y., Ito N. Rapid production of hyperplastic nodules in rats treated with carcinogenic chemicals: A new approach for an in vivo short-term screening test for hepatocarcinogens. Gann 1997; 68: 499–507
   Google Scholar
• Marasas W. F.O. Fumonisins: History, World-wide Occurrence and Impact. Adv. Expt. Med. Biol. 1996; 392: 1–17
   PubMedGoogle Scholar
• Marasas W. F.O., Jaskiewicz K., Venter F. S., Van Schalkwyk D. J. Fusarium moniliforme Contamination of Maize in Oesophageal Cancer Areas in Transkei. S. Afr. Med. J. 1988; 74: 110–114
   PubMed Web of Science ®Google Scholar
• Plattner R. D. Detection of Fumonisins Produced in Fusarium moniliforme Cultures by HPLC with Electrospray MS and Evaporative Light Scattering Detectors. Nat. Toxins 1995; 3: 294–298
   PubMedGoogle Scholar
• Seo J-A., Kim J-C., Lee Y-W. Isolation and Characterization of Two New Type C Fumonisins Produced by. Fusarium oxysporum, J. Nat. Prod. 1996; 59: 1003–1005
   Google Scholar
• Musser S. M., Gay M. L., Mazzola E. P. Identification of a New Series of Fumonisins Containing 3-Hydroxypyridine. J. Nat. Prod. 1996; 59: 970–972
   PubMed Web of Science ®Google Scholar
• Pachmayr O., Ledl F., Severin T. Bildung von 1-Alkyl-3-oxypyridiniumbetain aus Zuckern. Z. Lebensm. Unters. Forsch 1986; 182: 294–297
   Google Scholar
• Shier T. W., Tiefel A. P., Abbas K. H. Current Research on Mycotoxins: Fumonisins, in. Natural and Selected Synthetic Toxins: Biological Implications American Chemical Society Symposium Series, A. T. Tu, W. Gaffield. Oxford University Press, Oxford, U.K. 1999; 745: 54–66
   Google Scholar
• Riley T. R., Norred W. P., Bacon W. C. Fungal Toxins in Food: Recent Concerns. Annu. Rev. Nutr. 1993; 13: 167–189
   PubMed Web of Science ®Google Scholar
• Pittet A. Natural Occurrence of Mycotoxins in Foods and Feeds—an Updated Review. Revue Méd. Vét. 1998; 149: 479–492
   Web of Science ®Google Scholar
• Kellerman T S, Marasas W FO. Thiel PG, Gelderblom WCA, Cawood ME, Coetzer JAW. Leukoencephalomalacia in tow horses induced by oral dosing of fumonisin B1. Onderstopoort J. Vet. Res. 1990; 57: 269–275
   PubMed Web of Science ®Google Scholar
• Harrison L R, Colvin B M, Greene J T, Newman L E, Cole J R. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J. Vet. Diagn. Invest. 1990; 2: 217–221
   PubMedGoogle Scholar
• Gelderblom W CA, Kriek N PJ, Marasas W FO, Thiel P G. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 1991; 12: 1247–1251
   PubMed Web of Science ®Google Scholar
• Abbas K. H., Smeda R. J., Gerwick B. C., Shier W. T. Fumonisin B1 from the fungus Fusarium moniliforme causes contact toxicity in plants: Evidence from studies with biosynthetically labeled toxin. J. Nat. Toxins 1999; 8: 405–420
   PubMedGoogle Scholar
• Shier T. W., Abbas K. H., Mirocha J. C. Toxicity of the Mycotoxins Fumonisins B1 and B2 and Alternaria alternata f. sp. lycopersici Toxin (AAL) in Cultured Mammalian Cells. Mycopathologica 1991; 116: 97–104
   PubMed Web of Science ®Google Scholar
• Wattenberg E. V., Badria F. A., Shier W. T. Activation of Mitogen-activated Protein Kinase by the Carcinogenic Mycotoxin Fumonisin B1. Biochem. Biophys. Res. Commun. 1996; 227: 622–627
   PubMedGoogle Scholar
• Pinelli E., Pipy B., Castegnaro M., Miller D. J., Pfohl-Leszkowicz A. Fumonisin B1 Stimulates Arachidonic Acid Cascade by Activation of Mitogen-activated Protein Kinase. Revue Méd. Vét. 1998; 149: 651
   Google Scholar
• Pinelli E., Poux N., Garren L., Pipy B., Castegnaro M., Miller D. J., Pfohl-Leszkowicz A. Activation of Mitogen-activated Protein Kinase by Fumonisin B1 Stimulates cPLA2 Phosphorylation, the Arachidonic Acid Cascade and cAMP Production. Carcinogenesis 1999; 20: 1683–1688
   PubMed Web of Science ®Google Scholar
• Yeung J. M., Wang H-Y., Prelusky D. B. Fumonisin B1 Induces Protein Kinase C Translocation via Direct Interaction with Diacylglycerol Binding Site. Toxicol. Appl. Pharmacol. 1996; 141: 178–184
   PubMedGoogle Scholar
• Musser S. M., Eppley R. M., Mazzola E. P., Hadden C. E., Shockcor J. P., Crouch R. C., Martin G. E. Identification of An N-Acetyl Keto Derivative of Fumonisin B1 in Corn Cultures of Fusarium proliferatum. J. Nat. Prod. 1995; 58: 1392–1397
   PubMedGoogle Scholar
• Abbas H. K., Cartwright R. D., Shier W. T., Abouzied M. M., Bird C. B., Rice L. G., Ross P. F., Sciumbato G. L., Meredith F. I. Natural Occurrence of Fumonisins in Rice with Fusarium Sheath Rot Disease. Plant Disease 1998; 82: 22–25
   PubMed Web of Science ®Google Scholar
• Hopmans E. C., Murphy P. A. Detection of Fumonisins B1, B2, and B3 and Hydrolyzed Fumonisin B1 in Corn-containing Foods. J. Agric. Food Chem. 1993; 41: 1655–1658
   Web of Science ®Google Scholar
• Hendrich S., Miller K. A., Wilson T. M., Murphy P. A. Toxicity of Fusarium proliferatum-fermented Nixtamalized Corn-based Diets Fed to Rats: Effect of Nutritional Status. J. Agric. Food Chem. 1993; 41: 1649–1654
   Web of Science ®Google Scholar
• Stack M. E. Analysis of Fumonisin B1 and Its Hydrolysis Product in Tortillas. J. AOAC Intl. 1998; 81: 737–740
   PubMed Web of Science ®Google Scholar
• Shier W. T. The fumonisin paradox: A review of research on oral bioavailability of fumonisin B1, a mycotoxin produced by Fusarium moniliforme. J. Toxicol.-Toxin Rev. 2000; 19: 161–187
   Web of Science ®Google Scholar
• Makarieva T. N., Denisenko V. A., Stonik V. A., Milgrom Yu. M., Rashkes Ya. V. Rhizochalin, A Novel Secondary Metabolite of Mixed Biosynthesis from the Sponge Rhizochalina incrustata. Tetrahedron Lett. 1989; 30: 6581–6584
   Google Scholar
• Kong F., Faulkner D. J. Leucettamols A and B, Two Antimicrobial Lipids from the Calcareous Sponge Leucetta microraphis. J. Org. Chem. 1993; 58: 970–971
   Google Scholar
• Willis R. H., DeVries D. J. BRS1, A C30 Bis-amino, Bis-hydroxy Polyunsaturated Lipid from an Australian Calcareous Sponge that Inhibits Protein Kinase C. Toxicon 1997; 35: 1125–1129
   PubMedGoogle Scholar
• Grode S., Cardellina J. H. Ceramides from the Sponge. Dysidea etheria, Lipids 1983; 18: 889–893
   Google Scholar
• Chebaane K., Guyout M. Occurrence of Erythro-doccosasphinga-4, 8-dienine, as an Ester. Anemonia Sulcata, Tetrahedron Lett. 1986; 27: 1495–1496
   Google Scholar
• Kobayashi J., Ishibashi M., Nakamura H., Hirata Y., Yamasu T., Sasaki T., Ohizumi Y. Symbioramide, a novel Ca2+-ATPase activator from the cultured dinoflagellate Symbiodinium sp. Experientia 1988; 44: 800–802
   PubMedGoogle Scholar
• Nakagawa M., Yoshida J., Hino T. First Total Synthesis of Symbioramide, a Novel Ca2+-ATPase Activator from Symbiodinium sp. Chem. Lett. 1990; 1407–1410
   Google Scholar
• Yoshida J., Nakagawa M., Seki H., Hino T. Total Synthesis of Symbioramide, a Novel Ca2+-ATPase Activator from Symbiodinium sp. J. Chem. Soc. Perkin Trans. I. 1992; 1407–1410
   Google Scholar
• Hirsch S., Kashman Y. New Glycosphingolipids from Marine Organisms. Tetrahedron 1989; 45: 3897–3906
   Google Scholar
• Garg H. S., Agrawal S. A Novel Sphingosine Derivative from the Sponge Spirastrella inconstans. J. of Natural Products 1995; 58: 442–445
   Web of Science ®Google Scholar
• Bano S., Uddin S., Ahmad U. V. An Acetylated Derivative of a New N-Acylsphingosine from Red Alga. Halymenia porphyroides, Planta Medica 1990; 56: 233–234
   PubMedGoogle Scholar
• Rao Bheemasankara Ch., Satyanarayana Ch. A new sphingosine derivative from the red alga Halymenia durivilliae of Andaman and Nicobar Islands. Indian J. of Chem. 1994; 33B: 97–98
   Google Scholar
• Garg H. S., Sharma M., Bhakuni D. S. An Antiviral Sphingosine Derivative from the Green Alga. Ulva Fasciata, Tetrahedron Lett. 1992; 33: 1641–1644
   Web of Science ®Google Scholar
• Anjaneyulu V., Rao Subba P.V., Radhika P. A New Sphingosine Derivative and a Polyhydroxy Steroidal Glycoside from Sinularia gravis Tixier-Durivault of the Andaman and Nicobar Islands. Indian J. of Chem. 1999; 38B: 357–360
   Google Scholar
• Anjaneyulu V., Radhika P. Two New Sphingosine Derivatives from Sinularia crassa Tixier-Durivault of the Andaman and Nicobar Islands. Indian J. of Chem. 1999; 38B: 457–460
   Google Scholar
• Hoye T. R., Ayyad S-E. N., El Sayed K., Hashish N., Shier W. T. personal communication
   Google Scholar
• Smirnova G. P., Kochetkov N. K. A Novel Sialoglycolipid from Hepatopancreas of the Starfish. Patiria pectinifera, Biochimica et Biophysica Acta 1980; 618: 486–495
   PubMedGoogle Scholar
• Kawano Y., Higuchi R., Isobe R., Komori T. Isolation and Structure of Six New Cerebrosides. Liebigs Ann. Chem. 1988; 19–24
   Google Scholar
• Kawano Y., Higuchi R., Isobe R., Komori T. Isolation and Structure of Two New Ceramide Lactosides. Liebigs Ann. Chem. 1988; 1181–1183
   Google Scholar
• Kawano Y., Higuchi R., Komori T. Isolation and Structure of Five New Gangliosides. Liebigs Ann. Chem. 1990; 43–50
   Google Scholar
• Komori T., Sanechika Y., Ito Y., Matsuo J., Nohara T., Kawasaki T. Strukturen eines neuen Cerebrosidgemischs und von Nucleosiden aus dem Seestern. Acanthaster planci, Liebigs Ann. Chem. 1980; 653–668
   Google Scholar
• Higuchi R., Natori T., Komori T. Isolation and Characterization of Acanthacerebroside B and Structure Elucidation of Related, Nearly Homogeneous Cerebrosides. Liebigs Ann. Chem. 1990; 51–55
   Google Scholar
• Higuchi R., Inagaki K., Natori T., Komori T., Kawajiri S. Structure of Three Ganglioside Molecular Species and a Homogeneous Ganglioside, and Biological Activity of the Ganglioside. Liebigs Ann. Chem. 1991; 1–10
   Google Scholar
• Higuchi R., Kagoshima M., Komori T. Structures of Three New Cerebrosides, Astrocerebroside A, B, and C and of Related Nearly Homogeneous Cerebrosides. Liebigs Ann. Chem. 1990; 659–663
   Google Scholar
• Kobayashi E., Motoki K., Fukushima H., Koezuka Y. KRN7000, A Novel Immunomodulator, and Its Antitumor Activities. Oncology Res. 1995; 7: 529–534
   PubMed Web of Science ®Google Scholar
• Motoki K., Kobayashi E., Uchida T., Fukushima H., Koezuka Y. Antitumor Activities of α-, β-monogalactosylceramides and Four Diastereomers of an α-galactosylceramide. Bioorg. Med. Chem. Lett. 1995; 5: 705–710
   Web of Science ®Google Scholar
• Natori T., Koezuka Y., Higa T. Agelasphins, Novel α-galactosyl ceramides from the Marine Sponge. Agelas mauritianus, Tetrahedron Lett. 1993; 34: 5591–5592
   Web of Science ®Google Scholar
• Natori T., Morita M., Akimoto K., Koezuka Y. Agelasphins, Novel Antitumor and Immunostimulatory Cerebrosides from the Marine Sponge. Agelas Mauritianus, Tetrahedron 1994; 50: 2771–2784
   Web of Science ®Google Scholar
• Cafieri F., Fattorusso E., Mahajnah Y., Mangoni A. Longiside, a Novel Digalactosylceramide from the Caribbean Sponge. Agelas longissima, Liebigs Ann. Chem. 1994; 1187–1189
   Google Scholar
• Costantino V., Fattorusso E., Mangoni A. Glycolipids from Sponges. IV. Immunomodulating Glycosyl Ceramides from the Marine Sponge. Agelas dispar, Tetrahedron 1996; 52: 1573–1578
   Web of Science ®Google Scholar
• Costantino V., Fattorusso E., Mangoni A., Aknin M., Gaydou E. M. Axiceramide A an B, Two Novel Tri-α-glycosylceramides from the Marine Sponge. Axinella sp., Liebigs Ann. Chem. 1994; 1181–1185
   Google Scholar
• Hayashi A., Nishimura Y., Matsubara T. Occurrence of ceramide digalactoside as the main glycosphingolipid in the marine sponge. Halichondria japonica, Biochimica et Biophysica Acta 1991; 1083: 179–186
   PubMedGoogle Scholar
• Li H-Y., Matsunaga S., Fusetani N. Halicylindrosides, Antifungal and Cytotoxic Cerebrosides from the Marine Sponge. Halichondria cylindrata, Tetrahedron 1995; 51: 2273–2280
   Web of Science ®Google Scholar
• Higuchi R., Inagaki M., Togawa K., Miyamoto T., Komori T. Isolation and Structure of Cerebrosides from the Sea Cucumber. Pentacta australis, Liebigs Ann. Chem. 1994; 653–658
   Google Scholar
• Endo M., Nakagawa M., Hamamoto Y., Ishihama M. Pharmacologically Active Substances from Southern Pacific Marine Invertebrates. Pure & Appl. Chem. 1986; 58: 387–394
   Google Scholar
• Falsone G., Budzikiewicz H., Wendisch D. Uber Inhaltsstoffe von Euphorbiaceae 9. Mitt. Neue Cerebroside aus. Euphorbia biglangulosa Desf. Z. Naturforsch. 1987; 42b: 1476–1480
   Google Scholar
• Irie A., Kubo H., Hoshi M. Glucosylceramide Having a Novel Tri-Unsaturated Long-Chain Base from the Spermatozoa of the Starfish. Asterias amurensis, J. Biochem. 1990; 107: 578–586
   Google Scholar
• Jin W., Rinehart L., Jares-Erijman A. Ophidiacerebrosides: Cytotoxic Glycosphingolipids Containing a Novel Sphingosine from a Sea Star. J. Org. Chem. 1994; 59: 144–147
   Web of Science ®Google Scholar
• Higuchi R., Inagaki M., Togawa K., Miyamoto T., Komori T. Isolation and Structure of Three New Cerebrosides, CE-2b, CE-2c and CE-2d, from the Sea Cucumber. Cucumaria echinata, Liebigs Ann. Chem. 1994; 79–81
   Google Scholar
• Constantino V., Fattorusso E., Mangoni A., Di Rosa M., Ianaro A. Glycolipids from Sponges. 6. Plakoside A and B, Two Unique Prenylated Glycosphingolipids with Immunosuppressive Activity from the Marine Sponge. Plaakortis simplex, J. Am. Chem. Soc. 1997; 119: 12465–12470
   Google Scholar
• Bucci T. J., Howard P. C. Effect of Fumonisin Mycotoxins in Animals. J. Toxicol. Toxin Rev. 1996; 15: 293–302
   Google Scholar
• Bucci T. J., Howard P. C., Tolleson W. H., Laborde J. B., Hansen D. K. Renal Effects of Fumonisin Mycotoxins in Animals. Toxicol. Pathology 1998; 26: 160–164
   PubMedGoogle Scholar
• Abbas H. K., Duke S. O., Shier W. T., Riley R. T., Kraus G. A. The Chemistry and Biological Activities of the Natural Products AAL-toxin and the Fumonisins, in. Natural Toxins II: Structure, Mechanism of Action and Detection, B. R. Singh, A. T. Tu. American Chemical Society, Washington, D.C. 1996; 293–308
   Google Scholar
• Shier W. T., Abbas H. K., Badria F. A. Structure-activity Relationships of the Corn Fungal Toxin Fumonisin B1: Implications for Food Safety. J. Nat. Toxins 1977; 6: 225–242
   Google Scholar
• Abbas H. K., Boyette C. D. Phytotoxicity of Fumonisin B1 on Weed and Crop Species. Weed Technol. 1992; 40: 548–552
   Google Scholar
• Tanaka T., Abbas H. K., Duke S. O. Structure-dependent Phytotoxicity of Fumonisins and Related Compounds in a Duckweed Bioassay. Phytochemistry 1993; 33: 779–785
   Web of Science ®Google Scholar
• Abbas H. K., Gelderblom W. C. A., Cawood M. E., Shier W. T. Biological Activities of Fumonisins, Mycotoxins from Fusarium moniliforme in Jimsonweed (Datura stramonium L.) and Mammalian Cell Cultures. Toxicon 1993; 31: 345–353
   PubMedGoogle Scholar
• Abe A., Inokuchi J.-I., Jimbo M., Shimeno H., Nagamatsu A., Shayman J. A., Shukla G. S., Radin N. S. Improved Inhibitors of Glucosylceramide Synthase. J. Biochem. 1992; 111: 191–196
   PubMed Web of Science ®Google Scholar
• Abe A., Radin N. S., Shayman J. A., Wotring L. L., Zipkin R. E., Sivakumar R., Ruggieri J. M., Carson K. C., Ganem B. Structural and Stereochemical Studies of Potent Inhibitors of Glucosylceramide Synthase and Tumor Cell Growth. J. Lipid Res. 1995; 36: 611–621
   PubMed Web of Science ®Google Scholar